BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20456210)

  • 1. The impact of publishing medical specialty society guidelines on subsequent adoption of best practices: a case study with type 2 diabetes.
    Huang EA; Zdon GS; Moore RJ; Jane Moran H; Quick WW
    Int J Clin Pract; 2010 Apr; 64(5):558-61. PubMed ID: 20456210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
    Woo V;
    Diabetes Care; 2009 Mar; 32(3):e34; author reply e37-8. PubMed ID: 19246585
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs.
    Gadzhanova S; Roughead EE; Loukas K; Vajda J
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):359-65. PubMed ID: 21442685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term patterns of use after initiation of oral antidiabetic drug therapy.
    Lamberts EJ; Nijpels G; Welschen LM; Hugtenburg JG; Dekker JM; Souverein PC; Bouvy ML
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):351-8. PubMed ID: 21442684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Mannucci E; Monami M; Pala L; Cocca C; Cresci B; Bardini G; Masotti G; Marchionni N; Rotella CM
    Diabetes Care; 2007 Jan; 30(1):193-4. PubMed ID: 17192373
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Response to Nathan et al.
    Cobitz AR; Ambery P
    Diabetes Care; 2009 May; 32(5):e58; author rely e59. PubMed ID: 19407068
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Porta M; Trento M
    Diabetes Care; 2007 Jan; 30(1):193; author reply 194-6. PubMed ID: 17192374
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
    Eizirik DL
    Diabetes Care; 2009 Mar; 32(3):e35-6; author reply e37-8. PubMed ID: 19246586
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Parkin CG; Davidson JA
    Diabetes Care; 2007 Jan; 30(1):192-3; author reply 194-6. PubMed ID: 17192372
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Cryer PE
    Diabetes Care; 2007 Jan; 30(1):190-2; author reply 194-6. PubMed ID: 17192371
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
    Kirby M
    Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
    Jellinger PS; Lebovitz HE; Davidson JA;
    Diabetes Care; 2007 Apr; 30(4):e16-7; author reply e18-20, e21-2. PubMed ID: 17392531
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM; Buse JB; Davidson MB; Ferrannini E; Holman RR; Sherwin R; Zinman B
    Diabetes Care; 2008 Jan; 31(1):173-5. PubMed ID: 18165348
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.
    Barnett A
    Int J Clin Pract Suppl; 2007 Aug; (154):12-8. PubMed ID: 17593273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the management of type 2 diabetes: is ADA and EASD consensus more clinically relevant than the IDF recommendations?
    Czupryniak L
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S22-5. PubMed ID: 20115928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].
    Langendam MW; Hooijkaas C; Piepenbrink JF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1396-401. PubMed ID: 16841589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metformin role in the treatment of type 2 diabetes in 2008].
    Spada A; Philippe J
    Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy).
    Viswanathan V; Chacko PT; Lavanya M; Tilak P
    J Assoc Physicians India; 2006 Dec; 54():965-6. PubMed ID: 17334022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.